Related Experiment Videos
Bacterial ghosts as vaccine candidates for veterinary applications
Katri Jalava1, Andreas Hensel, Michael Szostak
1Biotech Innovation Research Development and Consulting (BIRD-C GmbH and CoKEG), Schoenborngasse 12, A-1080, Vienna, Austria. jalava@bird-c.com
Summary
The bacterial ghost system offers a novel vaccine approach for veterinary medicine. This innovative system enhances immune responses and allows for versatile combination vaccines, simplifying vaccine production and delivery.
Area of Science:
- Veterinary Medicine
- Immunology
- Biotechnology
Background:
- Developing effective vaccines is crucial for modern veterinary medicine.
- The bacterial ghost system presents a novel vaccine delivery platform with inherent adjuvant capabilities.
- Bacterial ghosts are nonliving bacterial cell envelopes preserving native antigens and bioadhesive properties.
Purpose of the Study:
- To evaluate the bacterial ghost system as a vaccine delivery platform in veterinary medicine.
- To highlight the intrinsic adjuvant properties of bacterial ghosts and their impact on immune responses.
- To showcase the versatility of bacterial ghosts for presenting multiple antigens.
Main Methods:
- Production of bacterial ghosts via PhiX174 protein E-mediated lysis of Gram-negative bacteria.
- Utilizing bacterial ghosts to present native and foreign antigens expressed on their surface.
- Assessing the enhancement of immune responses, including T-cell activation and mucosal immunity.
Main Results:
- Bacterial ghost preparations demonstrated intrinsic adjuvant properties, boosting immune responses.
- The system effectively enhances T-cell activation and mucosal immunity.
- Multiple antigens from various sources can be simultaneously presented using this versatile system.
Conclusions:
- The bacterial ghost system is a safe, simple, and effective vaccine delivery method for veterinary applications.
- Its independence from cold chain requirements and combination vaccine potential offer significant advantages.
- This technology enhances immune responses and provides a versatile platform for future vaccine development.